Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
Benjamin Wu(Amgen (United States)), Edward Lee(Baylor College of Medicine), Bethlyn Sloey(Amgen (United States)), Murad Melhem(Amgen (United States)), M. Benjamin Hock(Amgen (United States)), Andrew Chow(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gary L. Skiles, Ping Chen(Gansu University of Traditional Chinese Medicine), Bruno Fouqueray, Raju Subramanian(Gilead Sciences (United States))
Cited by 26
Related Papers
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
|The Journal of Experimental Medicine|2011|827
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
|Nephrology Dialysis Transplantation|2010|478
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325